|
EXOC8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41395792244248E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.04040109860648E-11 |
| Normal-vs-Stage2 |
4.82380002608807E-09 |
| Normal-vs-Stage3 |
9.07718344933528E-13 |
| Normal-vs-Stage4 |
1.4477308241112E-13 |
| Stage1-vs-Stage2 |
8.227000E-01 |
| Stage1-vs-Stage3 |
1.896370E-01 |
| Stage1-vs-Stage4 |
3.720400E-02 |
| Stage2-vs-Stage3 |
3.026600E-01 |
| Stage2-vs-Stage4 |
8.583900E-02 |
| Stage3-vs-Stage4 |
3.311000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.14146494875922E-12 |
| Normal-vs-AfricanAmerican |
1.003190E-04 |
| Normal-vs-Asian |
3.44040351762942E-11 |
| Caucasian-vs-AfricanAmerican |
7.927600E-02 |
| Caucasian-vs-Asian |
8.043400E-01 |
| AfricanAmerican-vs-Asian |
9.413500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.30846461338297E-13 |
| Normal-vs-Female |
8.37074853876629E-12 |
| Male-vs-Female |
1.173810E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.46469503192748E-11 |
| Normal-vs-Age(41-60Yrs) |
9.40358901857508E-13 |
| Normal-vs-Age(61-80Yrs) |
8.39772695826468E-12 |
| Normal-vs-Age(81-100Yrs) |
8.445700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.631200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.577200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.111600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.164000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.051200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.876000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.950100E-04 |
| Classical-VS-Follicular |
1.310240E-01 |
| Classical-VS-Other |
7.529500E-02 |
| Classical-VS-Normal |
1.84990023299747E-10 |
| Tall-VS-Follicular |
4.548300E-02 |
| Tall-VS-Other |
6.378200E-01 |
| Tall-VS-Normal |
6.3504757008559E-14 |
| Follicular-VS-Other |
2.309000E-01 |
| Follicular-VS-Normal |
1.90120141851935E-11 |
| Other-VS-Normal |
1.007820E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.72792899380647E-12 |
| Normal-vs-N1 |
1.89448456922037E-12 |
| N0-vs-N1 |
1.084380E-01 |
|
|
